TrialESMO open2025

The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.

S W M Lammers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.